메뉴 건너뛰기




Volumn 6, Issue , 2009, Pages

Enhanced anti-HCV activity of interferon alpha 17 subtype

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; RECOMBINANT ALPHA1 INTERFERON; RECOMBINANT ALPHA10 INTERFERON; RECOMBINANT ALPHA14 INTERFERON; RECOMBINANT ALPHA16 INTERFERON; RECOMBINANT ALPHA17 INTERFERON; RECOMBINANT ALPHA21 INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA4 INTERFERON; RECOMBINANT ALPHA5 INTERFERON; RECOMBINANT ALPHA6 INTERFERON; RECOMBINANT ALPHA7 INTERFERON; RECOMBINANT ALPHA8 INTERFERON; UNCLASSIFIED DRUG; VIRUS DNA; ALPHA INTERFERON; IFNA17 PROTEIN, HUMAN;

EID: 67649973476     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-70     Document Type: Article
Times cited : (26)

References (40)
  • 1
    • 0033916804 scopus 로고    scopus 로고
    • Epidemiology of hepatitis C: Geographic differences and temporal trends
    • 10.1055/s-2000-9506 10895428
    • Epidemiology of hepatitis C: geographic differences and temporal trends. A Wasley MJ Alter, Semin Liver Dis 2000 20 1 16 10.1055/s-2000-9506 10895428
    • (2000) Semin Liver Dis , vol.20 , pp. 1-16
    • Wasley, A.1    Alter, M.J.2
  • 2
    • 16544379964 scopus 로고    scopus 로고
    • The epidemiology of acute and chronic hepatitis C
    • 10.1016/S1089-3261(05)70321-4 15560058
    • The epidemiology of acute and chronic hepatitis C. MJ Alter, Clin Liver Dis 1997 1 559 568 10.1016/S1089-3261(05)70321-4 15560058
    • (1997) Clin Liver Dis , vol.1 , pp. 559-568
    • Alter, M.J.1
  • 3
    • 1542350630 scopus 로고    scopus 로고
    • NIH Consensus Statement on Management of Hepatitis C: 2002
    • NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements 2002 19 1 46
    • (2002) NIH Consens State Sci Statements , vol.19 , pp. 1-46
  • 4
    • 33646250428 scopus 로고    scopus 로고
    • The natural history of hepatitis C virus (HCV) infection
    • 16614742
    • The natural history of hepatitis C virus (HCV) infection. SL Chen TR Morgan, Int J Med Sci 2006 3 47 52 16614742
    • (2006) Int J Med Sci , vol.3 , pp. 47-52
    • Chen, S.L.1    Morgan, T.R.2
  • 5
    • 33947425672 scopus 로고    scopus 로고
    • The effects of HCV infection and management on health-related quality of life
    • DOI 10.1002/hep.21565
    • The effects of HCV infection and management on health-related quality of life. Z Younossi J Kallman J Kincaid, Hepatology 2007 45 806 816 10.1002/hep.21565 17326207 (Pubitemid 46450632)
    • (2007) Hepatology , vol.45 , Issue.3 , pp. 806-816
    • Younossi, Z.1    Kallman, J.2    Kincaid, J.3
  • 6
    • 34250621773 scopus 로고    scopus 로고
    • Hepatitis C virus: Virology, diagnosis and management of antiviral therapy
    • 17552030
    • Hepatitis C virus: virology, diagnosis and management of antiviral therapy. S Chevaliez JM Pawlotsky, World J Gastroenterol 2007 13 2461 2466 17552030
    • (2007) World J Gastroenterol , vol.13 , pp. 2461-2466
    • Chevaliez, S.1    Pawlotsky, J.M.2
  • 7
    • 33644520948 scopus 로고    scopus 로고
    • Therapy of hepatitis C: From empiricism to eradication
    • DOI 10.1002/hep.21064
    • Therapy of hepatitis C: from empiricism to eradication. JM Pawlotsky, Hepatology 2006 43 S207 220 10.1002/hep.21064 16447262 (Pubitemid 43303984)
    • (2006) Hepatology , vol.43 , Issue.2 SUPPL. 1
    • Pawlotsky, J.-M.1
  • 9
    • 34548758435 scopus 로고    scopus 로고
    • Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients
    • DOI 10.1002/hep.21781
    • Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients. TL Kieffer C Sarrazin JS Miller MW Welker N Forestier HW Reesink AD Kwong S Zeuzem, Hepatology 2007 46 631 639 10.1002/hep.21781 17680654 (Pubitemid 47436107)
    • (2007) Hepatology , vol.46 , Issue.3 , pp. 631-639
    • Kieffer, T.L.1    Sarrazin, C.2    Miller, J.S.3    Welker, M.W.4    Forestier, N.5    Reesink, H.W.6    Kwong, A.D.7    Zeuzem, S.8
  • 12
    • 9644262469 scopus 로고    scopus 로고
    • Interferons, interferon-like cytokines, and their receptors
    • DOI 10.1111/j.0105-2896.2004.00204.x
    • Interferons, interferon-like cytokines, and their receptors. S Pestka CD Krause MR Walter, Immunol Rev 2004 202 8 32 10.1111/j.0105-2896.2004.00204.x 15546383 (Pubitemid 39576902)
    • (2004) Immunological Reviews , vol.202 , pp. 8-32
    • Pestka, S.1    Krause, C.D.2    Walter, M.R.3
  • 13
    • 0141860843 scopus 로고    scopus 로고
    • Mechanisms of action of interferon and nucleoside analogues
    • 10.1016/S0168-8278(03)00207-1 14708685
    • Mechanisms of action of interferon and nucleoside analogues. H Thomas G Foster D Platis, J Hepatol 2003 39 Suppl 1 S93 98 10.1016/S0168-8278(03)00207-1 14708685
    • (2003) J Hepatol , vol.39 , Issue.SUPPL 1 , pp. 93-98
    • Thomas, H.1    Foster, G.2    Platis, D.3
  • 14
    • 0020629030 scopus 로고
    • Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells
    • 10.1016/0006-291X(83)91498-5 6303322
    • Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells. EN Fish K Banerjee N Stebbing, Biochem Biophys Res Commun 1983 112 537 546 10.1016/0006-291X(83)91498-5 6303322
    • (1983) Biochem Biophys Res Commun , vol.112 , pp. 537-546
    • Fish, E.N.1    Banerjee, K.2    Stebbing, N.3
  • 15
    • 0034767753 scopus 로고    scopus 로고
    • Antiviral actions of interferons
    • DOI 10.1128/CMR.14.4.778-809.2001
    • Antiviral actions of interferons. CE Samuel, Clin Microbiol Rev 2001 14 778 809 11585785 10.1128/CMR.14.4.778-809.2001 (Pubitemid 32979631)
    • (2001) Clinical Microbiology Reviews , vol.14 , Issue.4 , pp. 778-809
    • Samuel, C.E.1
  • 17
    • 0036787208 scopus 로고    scopus 로고
    • Different antiviral activities of IFN-alpha subtypes in human liver cell lines: Synergism between IFN-alpha2 and IFN-alpha8
    • 10.1016/S1386-6346(02)00020-7 12270738
    • Different antiviral activities of IFN-alpha subtypes in human liver cell lines: synergism between IFN-alpha2 and IFN-alpha8. S Yamamoto H Yano O Sanou H Ikegami M Kurimoto M Kojiro, Hepatol Res 2002 24 99 10.1016/S1386-6346(02)00020- 7 12270738
    • (2002) Hepatol Res , vol.24 , pp. 99
    • Yamamoto, S.1    Yano, H.2    Sanou, O.3    Ikegami, H.4    Kurimoto, M.5    Kojiro, M.6
  • 18
    • 0345188811 scopus 로고    scopus 로고
    • Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
    • DOI 10.1126/science.285.5424.110
    • Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. V Lohmann F Korner J Koch U Herian L Theilmann R Bartenschlager, Science 1999 285 110 113 10.1126/science.285.5424.110 10390360 (Pubitemid 29307577)
    • (1999) Science , vol.285 , Issue.5424 , pp. 110-113
    • Lohmann, V.1    Korner, F.2    Koch, J.-O.3    Herian, U.4    Theilmann, L.5    Bartenschlager, R.6
  • 24
    • 0035282841 scopus 로고    scopus 로고
    • Validation of an Mx/CAT reporter gene assay for the quantification of bovine type-I interferon
    • DOI 10.1016/S0022-1759(00)00359-8, PII S0022175900003598
    • Validation of an Mx/CAT reporter gene assay for the quantification of bovine type-I interferon. MD Fray GE Mann B Charleston, J Immunol Methods 2001 249 235 244 10.1016/S0022-1759(00)00359-8 11226480 (Pubitemid 32171975)
    • (2001) Journal of Immunological Methods , vol.249 , Issue.1-2 , pp. 235-244
    • Fray, M.D.1    Mann, G.E.2    Charleston, B.3
  • 26
    • 19944430095 scopus 로고    scopus 로고
    • Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection
    • DOI 10.1016/j.virol.2004.11.009, PII S004268220400769X
    • Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. I Bieche T Asselah I Laurendeau D Vidaud C Degot V Paradis P Bedossa DC Valla P Marcellin M Vidaud, Virology 2005 332 130 144 10.1016/j.virol.2004.11.009 15661146 (Pubitemid 40127235)
    • (2005) Virology , vol.332 , Issue.1 , pp. 130-144
    • Bieche, I.1    Asselah, T.2    Laurendeau, I.3    Vidaud, D.4    Degot, C.5    Paradis, V.6    Bedossa, P.7    Valla, D.-C.8    Marcellin, P.9    Vidaud, M.10
  • 27
    • 34547752462 scopus 로고    scopus 로고
    • Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins
    • DOI 10.1093/carcin/bgm075
    • Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins. A Budhu Y Chen JW Kim M Forgues K Valerie CC Harris XW Wang, Carcinogenesis 2007 28 1552 1560 10.1093/carcin/bgm075 17404395 (Pubitemid 47241805)
    • (2007) Carcinogenesis , vol.28 , Issue.7 , pp. 1552-1560
    • Budhu, A.1    Chen, Y.2    Kim, J.W.3    Forgues, M.4    Valerie, K.5    Harris, C.C.6    Wang, X.W.7
  • 29
    • 33845269751 scopus 로고    scopus 로고
    • Novel alpha interferon (IFN-α) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-α2b therapy in a subgenomic replicon system
    • DOI 10.1128/AAC.00199-06
    • Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon system. V Escuret A Martin D Durantel R Parent O Hantz C Trepo T Menguy E Bottius J Dardy J Maral, Antimicrob Agents Chemother 2006 50 3984 3991 17030563 10.1128/AAC.00199-06 (Pubitemid 44865139)
    • (2006) Antimicrobial Agents and Chemotherapy , vol.50 , Issue.12 , pp. 3984-3991
    • Escuret, V.1    Martin, A.2    Durantel, D.3    Parent, R.4    Hantz, O.5    Trepo, C.6    Menguy, T.7    Bottius, E.8    Dardy, J.9    Maral, J.10    Escary, J.L.11    Zoulim, F.12
  • 30
    • 33644522358 scopus 로고    scopus 로고
    • Inquiring into the differential action of interferons (IFNs): An IFN-α2 mutant with enhanced affinity to IFNAR1 Is functionally similar to IFN-β
    • DOI 10.1128/MCB.26.5.1888-1897.2006
    • Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. DA Jaitin LC Roisman E Jaks M Gavutis J Piehler J Van der Heyden G Uze G Schreiber, Mol Cell Biol 2006 26 1888 1897 16479007 10.1128/MCB.26.5.1888- 1897.2006 (Pubitemid 43297418)
    • (2006) Molecular and Cellular Biology , vol.26 , Issue.5 , pp. 1888-1897
    • Jaitin, D.A.1    Roisman, L.C.2    Jaks, E.3    Gavutis, M.4    Piehler, J.5    Van Der Heyden, J.6    Uze, G.7    Schreiber, G.8
  • 31
    • 0034704093 scopus 로고    scopus 로고
    • New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface
    • DOI 10.1074/jbc.M006854200
    • New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface. J Piehler LC Roisman G Schreiber, J Biol Chem 2000 275 40425 40433 10.1074/jbc.M006854200 10984492 (Pubitemid 32064677)
    • (2000) Journal of Biological Chemistry , vol.275 , Issue.51 , pp. 40425-40433
    • Piehler, J.1    Roisman, L.C.2    Schreiber, G.3
  • 32
    • 25144452720 scopus 로고    scopus 로고
    • Mutational analysis of the IFNAR1 binding site on IFNα2 reveals the architecture of a weak ligand-receptor binding-site
    • DOI 10.1016/j.jmb.2005.08.042, PII S0022283605009794
    • Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site. LC Roisman DA Jaitin DP Baker G Schreiber, J Mol Biol 2005 353 271 281 10.1016/j.jmb.2005.08.042 16171819 (Pubitemid 41356611)
    • (2005) Journal of Molecular Biology , vol.353 , Issue.2 , pp. 271-281
    • Roisman, L.C.1    Jaitin, D.A.2    Baker, D.P.3    Schreiber, G.4
  • 33
    • 35248864005 scopus 로고    scopus 로고
    • A structural basis for interferon-alpha-receptor interactions
    • 10.1096/fj.07-8585com 17517919
    • A structural basis for interferon-alpha-receptor interactions. J Kumaran L Wei LP Kotra EN Fish, Faseb J 2007 21 3288 3296 10.1096/fj.07-8585com 17517919
    • (2007) Faseb J , vol.21 , pp. 3288-3296
    • Kumaran, J.1    Wei, L.2    Kotra, L.P.3    Fish, E.N.4
  • 34
    • 33745966693 scopus 로고    scopus 로고
    • Variations in the Unstructured C-terminal Tail of Interferons Contribute to Differential Receptor Binding and Biological Activity
    • DOI 10.1016/j.jmb.2006.05.069, PII S0022283606006875
    • Variations in the unstructured C-terminal tail of interferons contribute to differential receptor binding and biological activity. M Slutzki DA Jaitin TB Yehezkel G Schreiber, J Mol Biol 2006 360 1019 1030 10.1016/j.jmb.2006.05.069 16815442 (Pubitemid 44062519)
    • (2006) Journal of Molecular Biology , vol.360 , Issue.5 , pp. 1019-1030
    • Slutzki, M.1    Jaitin, D.A.2    Yehezkel, T.B.3    Schreiber, G.4
  • 35
    • 33748450379 scopus 로고    scopus 로고
    • Complex Modulation of Cell Type-Specific Signaling in Response to Type I Interferons
    • DOI 10.1016/j.immuni.2006.08.014, PII S1074761306003992
    • Complex modulation of cell type-specific signaling in response to type I interferons. AH van Boxel-Dezaire MR Rani GR Stark, Immunity 2006 25 361 372 10.1016/j.immuni.2006.08.014 16979568 (Pubitemid 44354225)
    • (2006) Immunity , vol.25 , Issue.3 , pp. 361-372
    • Van Boxel-Dezaire, A.H.H.1    Rani, M.R.S.2    Stark, G.R.3
  • 36
    • 24144491592 scopus 로고    scopus 로고
    • Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation
    • DOI 10.1128/AAC.49.9.3770-3775.2005
    • Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation. C Francois I Bernard S Castelain B Charleston MD Fray JC Capiod G Duverlie, Antimicrob Agents Chemother 2005 49 3770 3775 16127052 10.1128/AAC.49.9.3770-3775.2005 (Pubitemid 41233030)
    • (2005) Antimicrobial Agents and Chemotherapy , vol.49 , Issue.9 , pp. 3770-3775
    • Francois, C.1    Bernard, I.2    Castelain, S.3    Charleston, B.4    Fray, M.D.5    Capiod, J.-C.6    Duverlie, G.7
  • 37
    • 0025331030 scopus 로고
    • Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein
    • 2161946
    • Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Pavlovic T Zurcher O Haller P Staeheli, J Virol 1990 64 3370 3375 2161946
    • (1990) J Virol , vol.64 , pp. 3370-3375
    • Pavlovic, J.1    Zurcher, T.2    Haller, O.3    Staeheli, P.4
  • 38
    • 0026929934 scopus 로고
    • Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth
    • 1382142
    • Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. EF Meurs Y Watanabe S Kadereit GN Barber MG Katze K Chong BR Williams AG Hovanessian, J Virol 1992 66 5805 5814 1382142
    • (1992) J Virol , vol.66 , pp. 5805-5814
    • Meurs, E.F.1    Watanabe, Y.2    Kadereit, S.3    Barber, G.N.4    Katze, M.G.5    Chong, K.6    Williams, B.R.7    Hovanessian, A.G.8
  • 40
    • 34250643546 scopus 로고    scopus 로고
    • The interferon inducing pathways and the hepatitis C virus
    • 17552028
    • The interferon inducing pathways and the hepatitis C virus. EF Meurs A Breiman, World J Gastroenterol 2007 13 2446 2454 17552028
    • (2007) World J Gastroenterol , vol.13 , pp. 2446-2454
    • Meurs, E.F.1    Breiman, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.